STIM (Neuronetics) Price-to-Free-Cash-Flow: N/A (As of Jun. 24, 2026)


STIM Neuronetics Inc STIM
51 GF Score
Price $1.32
GF Value $1.95
Valuation Possible Value Trap
! 4 Warning Signs
View Full Analysis

What is Neuronetics Price-to-Free-Cash-Flow?

As of today (2026-06-24), Neuronetics's share price is $1.315. Neuronetics's Free Cash Flow per Share for the trailing twelve months (TTM) ended in Mar. 2026 was $-0.20. Hence, Neuronetics's Price-to-Free-Cash-Flow Ratio for today is N/A.

The historical rank and industry rank for Neuronetics's Price-to-Free-Cash-Flow or its related term are showing as below:

STIM's Price-to-Free-Cash-Flow is not ranked *
in the Medical Devices & Instruments industry.
Industry Median: 23.6
* Ranked among companies with meaningful Price-to-Free-Cash-Flow only.

Neuronetics's Free Cash Flow per Share for the three months ended in Mar. 2026 was $-0.14. Its Free Cash Flow per Share for the trailing twelve months (TTM) ended in was $-0.20.

During the past 3 years, the average Free Cash Flow per Share Growth Rate was 36.70% per year. During the past 5 years, the average Free Cash Flow per Share Growth Rate was 21.30% per year.

During the past 10 years, Neuronetics's highest 3-Year average Free Cash Flow per Share Growth Rate was 88.70% per year. The lowest was 4.90% per year. And the median was 21.00% per year.


Neuronetics  (NAS:STIM) Price-to-Free-Cash-Flow Explanation

Free Cash Flow is considered more important than earnings by value investors. The reason is because, in principle, only the net cash that can be taken from the business belongs to shareholders. This Free Cash Flow can be used to grow the business, reduce debt or return to shareholders in dividends or share buybacks.

In a DCF Calculation Free Cash Flow is used to determine the intrinsic value of companies.


Be Aware

In real business, Free Cash Flow can be affected by the change in accounts receivable, accounts payable, management's decision on expansion, etc. Therefore, investors should look at the Free Cash Flow over the longer term. Long-term average of Free Cash Flow is a more reliable indicator for real free cash flow.


Neuronetics Price-to-Free-Cash-Flow Related Terms


Neuronetics Price-to-Free-Cash-Flow Historical Data

* Premium members only.

The historical data trend for Neuronetics's Price-to-Free-Cash-Flow can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Neuronetics Price-to-Free-Cash-Flow Chart

Neuronetics Annual Data
Trend Dec16 Dec17 Dec18 Dec19 Dec20 Dec21 Dec22 Dec23 Dec24 Dec25
Price-to-Free-Cash-Flow
Get a 7-Day Free Trial Premium Member Only Premium Member Only 0.00 0.00 0.00 0.00 0.00

Neuronetics Quarterly Data
Jun21 Sep21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23 Dec23 Mar24 Jun24 Sep24 Dec24 Mar25 Jun25 Sep25 Dec25 Mar26
Price-to-Free-Cash-Flow Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 0.00 0.00 0.00 0.00 0.00

STIM vs ZOMDF, RPID, OM: Price-to-Free-Cash-Flow Comparison

For the Medical Devices subindustry, Neuronetics's Price-to-Free-Cash-Flow, along with its competitors' market caps and Price-to-Free-Cash-Flow data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


Neuronetics Price-to-Free-Cash-Flow vs Medical Devices & Instruments Industry

For the Medical Devices & Instruments industry and Healthcare sector, Neuronetics's Price-to-Free-Cash-Flow distribution charts can be found below:

* The bar in red indicates where Neuronetics's Price-to-Free-Cash-Flow falls into.


STIM
51GF Score
Neuronetics Inc STIM
Price-to-Free-Cash-Flow is just one metric. See GF Score™, valuation, warning signs, and more.
View Full Analysis

Neuronetics Price-to-Free-Cash-Flow Calculation

Neuronetics's Price-to-Free-Cash-Flow ratio for today is calculated as

Price-to-Free-Cash-Flow Ratio=Share Price/ Free Cash Flow per Share (TTM)
=1.315/-0.198
=N/A

Neuronetics's Share Price of today is $1.315.
Neuronetics's Free Cash Flow per Share for the trailing twelve months (TTM) ended in Mar. 2026 adds up the quarterly data reported by the company within the most recent 12 months, which was $-0.20.

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

It can also be calculated from the numbers for the whole company:

Price-to-Free-Cash-Flow Ratio=Market Cap/Free Cash Flow

Is Neuronetics (STIM) Overvalued in 2026?

Based on GuruFocus' analysis, Neuronetics stock appears to be undervalued. The current stock price of $1.32 is trading 32.6% below its estimated GF Value™ of $1.95. GuruFocus considers Neuronetics to be Possible Value Trap.

Key valuation signals for STIM:

  • Price-to-Free-Cash-Flow: N/A
  • GF Value™: $1.95 vs. price of $1.32 (32.6% below fair value)
  • GF Score™: 51/100 with 4 warning signs

No single metric tells the full story. See the STIM stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.


Neuronetics Business Description

Other Exchanges NRC:Germany
Address 3222 Phoenixville Pike, Malvern, PA, USA, 19355
Neuronetics Inc a commercial-stage medical technology company focused on designing, developing, and marketing products that improve the quality of life for patients who suffer from psychiatric disorders. Its first commercial product, the NeuroStar Advance Therapy System, is a non-invasive and non-systemic office-based treatment that uses transcranial magnetic stimulation, or TMS, to create a pulsed, MRI-strength magnetic field that induces electrical currents designed to stimulate specific areas of the brain associated with mood. The company designed the NeuroStar Advance Therapy as a non-invasive therapeutic alternative to treat patients who suffer from MDD and to address the existing treatment options. The company operates in two segments: medical devices and clinic services.
51GF Score

Get the complete analysis for STIM

Price-to-Free-Cash-Flow is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.

$1.32
Price
$1.95
GF Value